• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

川崎病合并冠状动脉病变时血清肿瘤坏死因子、白细胞介素2受体及γ干扰素水平

Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions.

作者信息

Matsubara T, Furukawa S, Yabuta K

机构信息

Department of Pediatrics, Juntendo University School of Medicine, Tokyo, Japan.

出版信息

Clin Immunol Immunopathol. 1990 Jul;56(1):29-36. doi: 10.1016/0090-1229(90)90166-n.

DOI:10.1016/0090-1229(90)90166-n
PMID:2113446
Abstract

We investigated 45 patients with Kawasaki disease (KD) and report the first simultaneous determination of tumor necrosis factor (TNF), interleukin 2 receptor (IL-2R) and interferon-gamma (IFN-gamma) in the serum during acute phase. Serum levels of TNF were measured by a sandwich enzyme-linked immunosorbent assay. Serum levels of soluble IL-2R and IFN-gamma were measured by a sandwich enzyme immunoassay and radioimmunoassay, respectively. Serum levels of TNF, IL-2R, and IFN-gamma were seen to increase during the acute phase of KD. In KD patients with coronary-artery lesions (CAL), the percentage of positive cases for TNF (greater than or equal to 10 U/ml), IL-2R (greater than or equal to 1056 U/ml), and IFN-gamma (greater than or equal to 0.3 U/ml) was higher than that in patients without CAL. Our results suggest that aggressive activation of immunocompetent cells develops in KD with CAL.

摘要

我们对45例川崎病(KD)患者进行了研究,并首次报告了急性期血清中肿瘤坏死因子(TNF)、白细胞介素2受体(IL-2R)和干扰素-γ(IFN-γ)的同时测定情况。采用夹心酶联免疫吸附测定法检测血清TNF水平。分别采用夹心酶免疫测定法和放射免疫测定法检测血清可溶性IL-2R和IFN-γ水平。在KD急性期,可见血清TNF、IL-2R和IFN-γ水平升高。在患有冠状动脉病变(CAL)的KD患者中,TNF(≥10 U/ml)、IL-2R(≥1056 U/ml)和IFN-γ(≥0.3 U/ml)阳性病例的百分比高于无CAL的患者。我们的结果表明,在伴有CAL的KD中免疫活性细胞发生了强烈激活。

相似文献

1
Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions.川崎病合并冠状动脉病变时血清肿瘤坏死因子、白细胞介素2受体及γ干扰素水平
Clin Immunol Immunopathol. 1990 Jul;56(1):29-36. doi: 10.1016/0090-1229(90)90166-n.
2
[Serum gamma interferon levels in relation to tumor necrosis factor and interleukin 2 receptor in patients with Kawasaki disease involving coronary-artery lesions].[川崎病合并冠状动脉病变患者血清γ干扰素水平与肿瘤坏死因子及白细胞介素2受体的关系]
Arerugi. 1990 Feb;39(2 Pt 1):118-23.
3
[Role of ash2 (absent, small, or homeotic)-like and Jumonji domain-containing protein 3 on histone methylation of interferon-gamma gene and their associations with vascular damage of Kawasaki disease].[ash2(缺失、微小或同源异型)样蛋白和含Jumonji结构域蛋白3在干扰素-γ基因组蛋白甲基化中的作用及其与川崎病血管损伤的关系]
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Sep 24;45(9):791-798. doi: 10.3760/cma.j.issn.0253-3758.2017.09.012.
4
Serum Lp-PLA2 Level Predicting Coronary Artery Lesions in Children with Kawasaki Disease.血清 Lp-PLA2 水平预测川崎病患儿冠状动脉病变。
Heart Surg Forum. 2021 Jul 26;24(4):E611-E618. doi: 10.1532/hsf.3833.
5
Cytokines predict coronary aneurysm formation in Kawasaki disease patients.细胞因子可预测川崎病患者冠状动脉瘤的形成。
Eur J Pediatr. 1993 Apr;152(4):309-12. doi: 10.1007/BF01956740.
6
Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.川崎病患儿 NKG2D 表达水平异常降低。
Scand J Immunol. 2013 May;77(5):389-97. doi: 10.1111/sji.12022.
7
Soluble interleukin-2 receptors in children with Kawasaki syndrome.川崎病患儿的可溶性白细胞介素-2受体
Arthritis Rheum. 1990 Sep;33(9):1371-7. doi: 10.1002/art.1780330909.
8
[Soluble intercellular adhesion molecule-I levels in sera of patients with Kawasaki disease].[川崎病患者血清中可溶性细胞间黏附分子-1水平]
Arerugi. 1992 Oct;41(10):1507-14.
9
Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease.急性川崎病期间血清中p60可溶性肿瘤坏死因子受体水平
J Pediatr. 1994 May;124(5 Pt 1):721-5. doi: 10.1016/s0022-3476(05)81361-7.
10
Concentrations of cytokines, soluble interleukin-2 receptor, and soluble CD30 in sera of patients with hepatitis B virus infection during acute and convalescent phases.乙型肝炎病毒感染患者急性期和恢复期血清中细胞因子、可溶性白细胞介素-2受体及可溶性CD30的浓度。
Clin Diagn Lab Immunol. 2002 Nov;9(6):1372-5. doi: 10.1128/cdli.9.6.1372-1375.2002.

引用本文的文献

1
Five-Year Experience of Etanercept as Adjunct to Intravenous Immunoglobulin for Kawasaki Disease with Coronary Artery Involvement.依那西普作为静脉注射免疫球蛋白辅助药物治疗川崎病合并冠状动脉病变的五年经验
J Pediatr Clin Pract. 2025 Jul 16;17:200165. doi: 10.1016/j.jpedcp.2025.200165. eCollection 2025 Sep.
2
Establishment and validation of a nomogram for predicting intravenous immunoglobulin resistance and coronary artery lesion involvement in Kawasaki disease: a retrospective study.用于预测川崎病静脉注射免疫球蛋白抵抗及冠状动脉病变累及情况的列线图的建立与验证:一项回顾性研究
Clin Rheumatol. 2025 Feb;44(2):799-809. doi: 10.1007/s10067-025-07321-2. Epub 2025 Jan 14.
3
The Central Role of Interleukin-1 Signalling in the Pathogenesis of Kawasaki Disease Vasculitis: Path to Translation.
白细胞介素-1信号在川崎病血管炎发病机制中的核心作用:转化之路
Can J Cardiol. 2024 Dec;40(12):2305-2320. doi: 10.1016/j.cjca.2024.07.023. Epub 2024 Jul 30.
4
A bibliometric analysis of Kawasaki disease from 1974 to 2022.1974年至2022年川崎病的文献计量分析。
Heliyon. 2024 Mar 4;10(5):e27290. doi: 10.1016/j.heliyon.2024.e27290. eCollection 2024 Mar 15.
5
Efficacy and safety of infliximab in the treatment of Kawasaki disease: A systematic review and meta-analysis.英夫利昔单抗治疗川崎病的疗效和安全性:系统评价和荟萃分析。
Eur J Pediatr. 2024 Apr;183(4):1765-1776. doi: 10.1007/s00431-024-05437-2. Epub 2024 Jan 19.
6
Current knowledge of TNF-α monoclonal antibody infliximab in treating Kawasaki disease: a comprehensive review.目前关于 TNF-α 单克隆抗体英夫利昔单抗治疗川崎病的知识:全面综述。
Front Immunol. 2023 Oct 23;14:1237670. doi: 10.3389/fimmu.2023.1237670. eCollection 2023.
7
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: Common Inflammatory Pathways of Two Distinct Diseases.川崎病和儿童多系统炎症综合征:两种不同疾病的共同炎症途径。
Rheum Dis Clin North Am. 2023 Aug;49(3):647-659. doi: 10.1016/j.rdc.2023.03.002. Epub 2023 Mar 17.
8
Autoptic Findings in Cases of Sudden Death Due to Kawasaki Disease.川崎病所致猝死病例的尸体解剖结果
Diagnostics (Basel). 2023 May 23;13(11):1831. doi: 10.3390/diagnostics13111831.
9
Infliximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis.英夫利昔单抗用于强化川崎病和冠状动脉瘤患者的初始治疗。
Arch Dis Child. 2023 Oct;108(10):833-838. doi: 10.1136/archdischild-2023-325639. Epub 2023 May 31.
10
Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer.抗集落刺激因子2的动脉粥样硬化相关血清抗体在预测急性缺血性卒中发病及结直肠癌预后中的应用
Front Cardiovasc Med. 2023 Feb 10;10:1042272. doi: 10.3389/fcvm.2023.1042272. eCollection 2023.